Published
In this educational webinar, Dr. Scott Sellinger discusses why comprehensive genomic profiling (CGP) is important in advanced prostate cancer. He reviews pertinent guidelines and FDA-approved biomarker driven therapies for patients with advanced prostate cancer and briefly discusses the differences between genetic and genomic testing for these patients.
- Categoria
- Urology
Commenta per primo questo video.
Prossimo
-
19:35
Advanced Prostate Cancer: Understanding ctDNA Tumor Fraction: A Pioneers in Practice Webinar
-
11:16
Multi-Disciplinary Approach to Advanced Prostate Cancer Care with Dr. Kelvin Moses
-
07:45
Comparing Alpha and Beta Emitters, and Looking to the Future of Advanced Prostate Cancer Care
-
09:58
Advanced prostate cancer vlog - update on oncology appointment.
-
09:45
New Treatments for Advanced Prostate Cancer
-
15:04
Why Psychology is important to nursing practice
-
05:29
2025 EAU Prostate Cancer Guidelines update: High risk, locally advanced and biochemical recurrence
-
18:06
Justin J. Badal - AUA 2024 Advanced Prostate Cancer Guidelines
-
12:47
Why It’s Important to Screen for Prostate Cancer
-
06:35
✅ Robotic Prostatectomy: ✅ Most Advanced Prostate Cancer Treatment in Delhi NCR | Dr. Amit Bansal
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
